Log In
News

C-Suite Interview with Baudax Bio (BXRX) President & CEO Gerri Henwood

3/1/2022
Health
0 min read

Noble Capital Markets Senior Research Analyst Gregory Aurand sits down with Baudax Bio President & CEO Gerri Henwood for this exclusive interview.

Research, News, and Advanced Market Data on BXRX


View all C-Suite Interviews


The 2022 C-Suite Interview series is now available on major podcast platforms

About Baudax Bio

Baudax Bio is a pharmaceutical company focused on commercializing and developing innovative products for acute care settings. ANJESO is the first and only 24-hour, intravenous (IV) COX-2 preferential non-steroidal anti-inflammatory (NSAID) for the management of moderate to severe pain. In addition to ANJESO, Baudax Bio has a pipeline of other innovative pharmaceutical assets including two novel neuromuscular blocking agents (NMBs) and a proprietary chemical reversal agent specific to these NMBs. For more information, please visit www.baudaxbio.com.

Share
Related News
‌
Release – NN, Inc. To Hold First Quarter 2024 Earnings Conference Call On Tuesday, May 7, 2024
4/24/2024
Industrials

Release – NN, Inc. To Hold First Quarter 2024 Earnings Conference Call On Tuesday, May 7, 2024

NN, Inc. (NASDAQ: NNBR), a global diversified industrial company that engineers and manufactures high-precision components and assemblies, announced today that it will release its first quarter 2024 financial results for...
2 min read
‌
Release – Kelly Announces First-Quarter 2024 Conference Call
4/24/2024
Business

Release – Kelly Announces First-Quarter 2024 Conference Call

Kelly, a leading global specialty talent solutions provider, will release its first-quarter earnings before the market opens on Thursday, May 9, 2024. In conjunction with its first-quarter earnings release, Kelly...
2 min read
‌
Release – Travelzoo Reports First Quarter 2024 Results
4/24/2024
Media and Entertainment

Release – Travelzoo Reports First Quarter 2024 Results

Research News and Market Data on TZOO NEW YORK, April 24, 2024 /PRNewswire/ — Travelzoo® (NASDAQ: TZOO): Travelzoo, the club for travel enthusiasts, today announced financial results for the first quarter ended March 31, 2024....
7 min read
‌
The End of TikTok in the US As We Know It?
4/24/2024
Consumer

The End of TikTok in the US As We Know It?

In a historic move with far-reaching implications, President Joe Biden signed into law a bipartisan bill on Wednesday that gives Chinese company ByteDance one year to sell or spin off...
3 min read

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
Log In
© 2018-2024 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.
Log In